Providence is calling a Post Doctorate Fellow (1.0 FTE) to Providence Portland Medical Center in Portland OR. A highly motivated and hardworking individual is sought to join the Antitumor T-cell Response Lab as a Postdoctoral fellow at the Earle A. Chiles Research Institute (EACRI).
The major goal of this lab is to develop new and more effective adoptive T-cell transfer immunotherapies to treat patients with metastatic epithelial cancers. The fellowship will be focused on developing and evaluating novel gene engineering strategies to enhance the function of T cells for adoptive immunotherapy.
The EACRI contains a cleanroom facility that is capable of generating cellular products for treating patients in early phase clinical trials. Thus, promising findings can be directly translated into experimental therapies that can be used to treat patients with cancer here at Providence Cancer Institute. A strong working knowledge of molecular biology and experience in genetic engineering of lymphocytes are major assets. Other assets include experience with immunological techniques such as enzyme-linked immunosorbent assay (ELISA), ELISPOT assay, multicolor flow cytometry, and T-cell culture.
At the Earle A. Chiles Research Institute at Providence, we strive to create a training environment that stimulates creativity and nurtures professionalism, and puts postdoctoral fellows on a path to their future. Fellowships are for one year and may be renewed annually based on demonstrated progress of the Fellows IDP and will not typically extend past 5 years. Fellows are expected to apply for external funding within 2 years of their assignment and are expected to submit at least one 1st author manuscript within the first 3 years of their assignment; then one per year thereafter.
In this position, you will:
Required qualifications for this position include:
About Providence in Oregon
As the largest healthcare system and largest private employer in Oregon, Providence offers exceptional work environments and unparalleled career opportunities.